Company Profile

Smart Quotes

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila

BSE1001.001.6 (+0.16 %)

PREV CLOSE ( ) 999.40

OPEN PRICE ( ) 999.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 37544

TODAY'S LOW / HIGH ( )999.00 1014.25

52 WK LOW / HIGH ( )797.05 1323.9

NSE1001.001.6 (+0.16 %)

PREV CLOSE( ) 999.40

OPEN PRICE ( ) 1004.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1001.00 (259)

VOLUME 845835

TODAY'S LOW / HIGH( ) 999.00 1014.85

52 WK LOW / HIGH ( )795 1324.3

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995

Management Info

Pankaj R Patel - Chairman Sharvil P Patel - Managing Director

Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079-71800000 / 48040000

Email dhavalsoni@zyduscadila.com

Website www.zyduscadila.com

Registrars Details

MUFG Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE

NEWS

03Jul Zydus Lifesciences informs about newsp
Zydus Lifesciences has informed that it enclosed the newspaper cutting d..

19Jun USFDA concludes GMP follow-up inspecti
US Food and Drug Administration (USFDA) has concluded GMP follow-up insp..

19Jun Zydus Lifesciences informs about inve
Zydus Lifesciences has informed that the management of the Company will..

19Jun Announcement under Regulation 30 (LOD
Closure of USFDA inspection at Zydus'' oncology injectable plant at Ahme..

12Jun Zydus Lifesciences gets EIR for Ankles
Zydus Lifesciences has received the Establishment Inspection Report (EIR..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	28137	57749
Gross Profit	36747	74447
Operating Profit	39581	84325
Net Sales	58196	151163

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 11998.85 (2.99%)	M.Cap ( in Cr)15394.39
Sanofi Cons. Health (BSE) 5361.70 (3.17%)	M.Cap ( in Cr)12348.33
Mankind Pharma (BSE) 2439.30 (3.21%)	M.Cap ( in Cr)100676.92
Alkem Laboratories (BSE) 4884.80 (1.34%)	M.Cap ( in Cr)58405.11
Albert David (BSE) 947.65 (6.57%)	M.Cap ( in Cr)540.84

Shareholding Pattern

	PROMOTERS	74.99%
	NON-INSTITUTION	6.68%
	MUTUAL FUNDS/UTI	6.36%
	FI/BANKS/INSURANCE	4.4%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quant Healthcare Fund-Reg(G)	7.02
Quant Large Cap Fund-Reg(G)	5.18
NJ ELSS Tax Saver Scheme-Reg(G)	3.84
Quant Quantamental Fund-Reg(G)	3.19
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)	3.10
Nippon India Nifty Pharma ETF	2.95
Baroda BNP Paribas Focused Fund-Reg(G)	2.93